Endogenous TSH levels at the time of 131I ablation do not influence ablation success, recurrence-free survival or differentiated thyroid cancer-related mortality
Crossref DOI link: https://doi.org/10.1007/s00259-015-3223-2
Published Online: 2015-10-23
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vrachimis, Alexis
Riemann, Burkhard
Mäder, Uwe
Reiners, Christoph
Verburg, Frederik A.
Text and Data Mining valid from 2015-10-23